These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6300368)

  • 1. Systemic absorption of delta 9-tetrahydrocannabinol after ophthalmic administration to the rabbit.
    Chiang CW; Barnett G; Brine D
    J Pharm Sci; 1983 Feb; 72(2):136-8. PubMed ID: 6300368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinol.
    McCallum ND; Yagen B; Levy S; Mechoulam R
    Experientia; 1975 May; 31(5):520-1. PubMed ID: 1140243
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of systemic absorption between ofloxacin ophthalmic in situ gels and ofloxacin conventional ophthalmic solutions administration to rabbit eyes by HPLC-MS/MS.
    Li J; Zhao H; Okeke CI; Li L; Liu Z; Yin Z; Zhuang P; Sun J; Wu T; Wang M; Li N; Pi J; Zhang Q; Zhang R; Ma L; Pang X; Liu Z; Zhang L; Fan L
    Int J Pharm; 2013 Jun; 450(1-2):104-13. PubMed ID: 23612359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. delta 9-Tetrahydrocannabinol transport in rabbit eyes.
    Krupin T; Fritz C; Dutton JJ; Becker B
    Exp Eye Res; 1980 Apr; 30(4):345-50. PubMed ID: 6256192
    [No Abstract]   [Full Text] [Related]  

  • 5. Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey.
    Perlin E; Smith CG; Nichols AI; Almirez R; Flora KP; Cradock JC; Peck CC
    J Pharm Sci; 1985 Feb; 74(2):171-4. PubMed ID: 2985774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between delta-9-tetrahydrocannabinol and indomethacin.
    Green K; Kearse EC; McIntyre OL
    Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Disposition of ∆
    Punyamurthula NS; Adelli GR; Gul W; Repka MA; ElSohly MA; Majumdar S
    AAPS PharmSciTech; 2017 Aug; 18(6):1936-1945. PubMed ID: 27905004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of the disposition of 14C-delta 9-tetrahydrocannabinol and 3H-delta 9-tetrahydrocannabinol.
    Siemens AJ; Doyle OL; Pryor GT
    Life Sci; 1979 Apr; 24(14):1261-74. PubMed ID: 470542
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication?
    Hollister LE; Gillespie HK; Ohlsson A; Lindgren JE; Wahlen A; Agurell S
    J Clin Pharmacol; 1981; 21(S1):171S-177S. PubMed ID: 6271822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular pharmacokinetics of subconjunctivally versus intravenously administered 6-mercaptopurine.
    Gudauskas G; Kumi C; Dedhar C; Bussanich N; Rootman J
    Can J Ophthalmol; 1985 Apr; 20(3):110-3. PubMed ID: 4039967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution studies of (14C)delta-9-tetrahydrocannabinol in mice: effect of vehicle, route of administration, and duration of treatment.
    Mantilla-Plata B; Harbison RD
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):292-300. PubMed ID: 1209626
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.
    Ohlsson A; Lindgren JE; Wahlen A; Agurell S; Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1980 Sep; 28(3):409-16. PubMed ID: 6250760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.
    Wall ME; Sadler BM; Brine D; Taylor H; Perez-Reyes M
    Clin Pharmacol Ther; 1983 Sep; 34(3):352-63. PubMed ID: 6309462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. delta-9-Tetrahydrocannabinol uptake by adipose tissue: preferential accumulation in gonadal fat organs.
    Rawitch AB; Rohrer R; Vardaris RM
    Gen Pharmacol; 1979; 10(6):525-9. PubMed ID: 520807
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and tissue distribution of tacrolimus (FK506) after a single or repeated ocular instillation in rabbits.
    Fujita E; Teramura Y; Shiraga T; Yoshioka S; Iwatsubo T; Kawamura A; Kamimura H
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):309-19. PubMed ID: 18476801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of azone and hexamethylene lauramide in toxicologic effects and penetration enhancement of cimetidine in rabbit eyes.
    Ismail IM; Chen CC; Richman JB; Andersen JS; Tang-Liu DD
    Pharm Res; 1992 Jun; 9(6):817-21. PubMed ID: 1409367
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of thymoxamine in rabbits after ophthalmic and intravenous administration.
    Aldana I; González-Peñas E; Fos D; Bruseghini L; Esteras A; Ceppi Monti N; Gianesello V
    Eur J Drug Metab Pharmacokinet; 1994; 19(2):79-83. PubMed ID: 8001598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic absorption of topical ocularly applied epinephrine and dipivefrin.
    Anderson JA
    Arch Ophthalmol; 1980 Feb; 98(2):350-3. PubMed ID: 7352887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.